Funding

Funding

Startup A-Alpha Bio Sets Out To Solve A Major Protein Problem Facing Big Pharma

• Posted onSeptember 13, 2021 Last Updated: September 13, 2021
• By: Kaitlyn Grosse

Funding

Life-Sciences Investment Volume Hit $9B in First Half of 2021, Tracking To a Record Year for CRE Sector

• Posted onSeptember 7, 2021 Last Updated: September 7, 2021
• By: Kaitlyn Grosse

Funding

Biotech Companies Fuel IPO Boom in Washington State Over the Past Year

• Posted onAugust 30, 2021 Last Updated: August 30, 2021
• By: Kaitlyn Grosse

Funding

In Washington’s Life Sciences Sector, A Streak of Companies Going Public

• Posted onAugust 9, 2021 Last Updated: August 9, 2021
• By: Kaitlyn Grosse

Funding

Icosavax Stock Skyrockets 200% on First Day of Trading for Newly Public Seattle Biotech Company

• Posted onAugust 2, 2021 Last Updated: August 2, 2021
• By: Kaitlyn Grosse

Funding

Absci Shares Spike 30% in IPO Debut, Valuing Washington State Biotech Company at Nearly $2B

• Posted onJuly 26, 2021 Last Updated: July 26, 2021
• By: Kaitlyn Grosse

Funding

Eliem Therapeutics Files for IPO as Another Seattle-Area Biotech Firm Set to Go Public

• Posted onJuly 26, 2021 Last Updated: July 26, 2021
• By: Kaitlyn Grosse

Funding

Ultrapotent, Nanoparticle COVID-19 Vaccine with University of Washington Roots Gets $173M for Human Trials

• Posted onJune 7, 2021 Last Updated: June 7, 2021
• By: Kaitlyn Grosse

Funding

Seattle’s Eliem Therapeutics Raises $60M to Advance Drug Pipeline

• Posted onJune 2, 2021 Last Updated: June 2, 2021
• By: Kaitlyn Grosse

Funding

Sana Biotechnology Sets Sights on Growth After $587.5M IPO

• Posted onMay 24, 2021 Last Updated: May 24, 2021
• By: Kaitlyn Grosse